Results 171 to 180 of about 1,949,500 (369)

From 2D to 3D gamma passing rate tolerance and action limits for patient‐specific quality assurance in volumetric‐modulated arc therapy

Journal of Applied Clinical Medical Physics, EarlyView.
Abstract Background Volumetric modulated arc therapy (VMAT) requires an accurate patient‐specific quality assurance (PSQA) program. In clinical practice, this is usually performed using the γ‐index and the two‐dimensional gamma passing rate (2D %GP). A three‐dimensional (3D) index incorporating the patient anatomy could be more useful for the 3D dose ...
Christos Zarros, George Patatoukas, Nikos Kollaros, Marina Chalkia, Andromachi Kougioumtzopoulou, Vasilios Kouloulias, Kalliopi Platoni   +6 more
wiley   +1 more source

Validity of psychiatric diagnoses in patients with substance use disorders: Is the interview more important than the interviewer?

, 1995
Henry R. Kranzler, Ronald M. Kadden, Joseph A. Burleson, Thomas F. Babor, Andrew Apter, Bruce J. Rounsaville   +5 more
openalex   +1 more source

Behavioral therapies for co-occurring substance use and mood disorders [PDF]

, 2004
Kathleen M. Carroll
openalex   +1 more source

A review of artificial intelligence in brachytherapy

Journal of Applied Clinical Medical Physics, EarlyView.
Abstract Artificial intelligence (AI) has the potential to revolutionize brachytherapy's clinical workflow. This review comprehensively examines the application of AI, focusing on machine learning and deep learning, in various aspects of brachytherapy.
Jingchu Chen, Richard L. J. Qiu, Tonghe Wang, Shadab Momin, Xiaofeng Yang   +4 more
wiley   +1 more source

Psychopathology Risk Transmission in Children of Parents With Substance Use Disorders [PDF]

, 2004
Duncan B. Clark, Jack R. Cornelius, David Wood, Michael M. Vanyukov   +3 more
openalex   +1 more source

A positive psychology framework for why people use substances: Implications for treatment

Frontiers in Psychology, 2022
Bryant M. Stone
doaj   +1 more source

Pharmacogenetic aspects of substance use disorders

Обозрение психиатрии и медицинской психологии имени В.М. Бехтерева, 2018
The substance use disorders Diseases of substance dependence (SAW) represent the «pharmacogenetic» diseases caused by abnormal and genetically determined response of the CNS to use of the substance of abuse (SA), conscious and regulated by person itself.
A. O. Kibitov
doaj  

Leveraging Large Language Models to Extract Information on Substance Use Disorder Severity from Clinical Notes: A Zero-shot Learning Approach [PDF]

arXiv
Substance use disorder (SUD) poses a major concern due to its detrimental effects on health and society. SUD identification and treatment depend on a variety of factors such as severity, co-determinants (e.g., withdrawal symptoms), and social determinants of health.
arxiv  

Evaluation of the effect of metal stents on dose perturbation in the carbon beam irradiation field

Journal of Applied Clinical Medical Physics, EarlyView.
Abstract Propose Carbon ion therapy is indicated for cases in which stents have been inserted, such as bile ducts, but the effect of metal stents on carbon ion therapy is unclear. In this study, the dose perturbation of carbon ion therapy caused by metallic bile duct stents was evaluated by dosimetry. Materials and methods Five different types of metal
Yuya Miyasaka, Tetsuya Ishizawa, Yoshihito Nawa, Hikaru Souda, Shohei Kawashiro, Hongbo Chai, Miyu Ishizawa, Hiraku Sato, Takeo Iwai   +8 more
wiley   +1 more source

Selection of a substance use disorder diagnostic instrument by the National Drug Abuse Treatment Clinical Trials Network [PDF]

, 2004
Robert Forman, Dace S. Svikis, Iván D. Montoya, Jack Blaine   +3 more
openalex   +1 more source